Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testosterone | 21 | 2014 | 181 | 2.960 |
Why?
|
| Muscle, Skeletal | 17 | 2014 | 257 | 2.260 |
Why?
|
| Oxidative Stress | 11 | 2019 | 874 | 1.700 |
Why?
|
| Muscle Fibers, Skeletal | 7 | 2014 | 60 | 1.660 |
Why?
|
| Apoptosis | 9 | 2016 | 1317 | 1.470 |
Why?
|
| Cystine | 3 | 2013 | 12 | 1.210 |
Why?
|
| Nicotine | 6 | 2018 | 238 | 1.210 |
Why?
|
| Acetylcysteine | 3 | 2011 | 58 | 1.110 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 5 | 2013 | 73 | 0.940 |
Why?
|
| Myocytes, Cardiac | 2 | 2016 | 165 | 0.860 |
Why?
|
| Aging | 5 | 2013 | 639 | 0.840 |
Why?
|
| Fatty Liver | 5 | 2019 | 56 | 0.830 |
Why?
|
| Sarcopenia | 2 | 2013 | 9 | 0.830 |
Why?
|
| Satellite Cells, Skeletal Muscle | 3 | 2006 | 8 | 0.780 |
Why?
|
| Antioxidants | 3 | 2013 | 386 | 0.730 |
Why?
|
| Mice, Inbred C57BL | 13 | 2019 | 1530 | 0.730 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2010 | 84 | 0.700 |
Why?
|
| Mitochondria | 3 | 2014 | 454 | 0.690 |
Why?
|
| Signal Transduction | 8 | 2018 | 1802 | 0.670 |
Why?
|
| Receptors, Notch | 3 | 2014 | 32 | 0.530 |
Why?
|
| Parabiosis | 1 | 2014 | 2 | 0.510 |
Why?
|
| Muscle Development | 2 | 2014 | 44 | 0.500 |
Why?
|
| Selenomethionine | 2 | 2011 | 10 | 0.490 |
Why?
|
| Prediabetic State | 1 | 2014 | 51 | 0.460 |
Why?
|
| Male | 32 | 2019 | 18870 | 0.460 |
Why?
|
| Caspase 2 | 2 | 2014 | 6 | 0.460 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 94 | 0.460 |
Why?
|
| Spermine | 2 | 2010 | 64 | 0.450 |
Why?
|
| Glutathione | 2 | 2010 | 160 | 0.440 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 93 | 0.430 |
Why?
|
| Vitamin D | 1 | 2014 | 176 | 0.430 |
Why?
|
| Minocycline | 1 | 2011 | 5 | 0.410 |
Why?
|
| Dietary Fats | 2 | 2011 | 115 | 0.400 |
Why?
|
| Animals | 19 | 2019 | 14307 | 0.400 |
Why?
|
| Maternal Exposure | 1 | 2011 | 30 | 0.400 |
Why?
|
| Mice | 14 | 2019 | 5668 | 0.400 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 65 | 0.390 |
Why?
|
| Myostatin | 4 | 2009 | 57 | 0.390 |
Why?
|
| Hypertrophy | 4 | 2014 | 31 | 0.380 |
Why?
|
| Inflammation | 2 | 2014 | 577 | 0.370 |
Why?
|
| Down-Regulation | 1 | 2011 | 420 | 0.350 |
Why?
|
| Muscular Diseases | 1 | 2009 | 20 | 0.340 |
Why?
|
| Cocaine | 1 | 2011 | 219 | 0.330 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 1300 | 0.330 |
Why?
|
| AMP-Activated Protein Kinases | 4 | 2018 | 49 | 0.320 |
Why?
|
| Cardiotoxins | 1 | 2007 | 2 | 0.320 |
Why?
|
| Obesity | 2 | 2014 | 965 | 0.300 |
Why?
|
| Receptors, Androgen | 2 | 2004 | 122 | 0.300 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2014 | 91 | 0.290 |
Why?
|
| Immunohistochemistry | 5 | 2019 | 859 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2011 | 139 | 0.280 |
Why?
|
| Enzyme Activation | 4 | 2010 | 423 | 0.270 |
Why?
|
| Nitric Oxide | 1 | 2007 | 287 | 0.270 |
Why?
|
| Body Composition | 7 | 2011 | 146 | 0.250 |
Why?
|
| Hepatocytes | 3 | 2014 | 74 | 0.240 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 685 | 0.240 |
Why?
|
| Organ Size | 3 | 2014 | 148 | 0.230 |
Why?
|
| Weight Loss | 5 | 2006 | 124 | 0.220 |
Why?
|
| Humans | 26 | 2019 | 34853 | 0.210 |
Why?
|
| Phosphorylation | 3 | 2016 | 878 | 0.200 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2011 | 72 | 0.190 |
Why?
|
| HIV Infections | 7 | 2006 | 2207 | 0.170 |
Why?
|
| Cotinine | 1 | 2019 | 40 | 0.170 |
Why?
|
| Aldehydes | 2 | 2010 | 65 | 0.170 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 51 | 0.170 |
Why?
|
| Menstrual Cycle | 1 | 1998 | 34 | 0.160 |
Why?
|
| Myogenin | 2 | 2009 | 5 | 0.160 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2009 | 42 | 0.160 |
Why?
|
| Triglycerides | 3 | 2014 | 129 | 0.160 |
Why?
|
| Adult | 17 | 2014 | 11034 | 0.160 |
Why?
|
| Models, Biological | 3 | 2016 | 642 | 0.160 |
Why?
|
| Benzamides | 1 | 2018 | 76 | 0.150 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 34 | 0.150 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 32 | 0.150 |
Why?
|
| Caspases | 1 | 2016 | 132 | 0.140 |
Why?
|
| Middle Aged | 13 | 2014 | 9642 | 0.140 |
Why?
|
| Body Weight | 3 | 2014 | 404 | 0.140 |
Why?
|
| Placebos | 2 | 2014 | 38 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2014 | 66 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 3 | 2003 | 183 | 0.130 |
Why?
|
| C-Reactive Protein | 2 | 2014 | 147 | 0.130 |
Why?
|
| Microscopy, Confocal | 2 | 2006 | 210 | 0.130 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2014 | 22 | 0.130 |
Why?
|
| Cell Count | 2 | 2006 | 129 | 0.130 |
Why?
|
| Microscopy, Electron | 2 | 2006 | 186 | 0.130 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2014 | 8 | 0.120 |
Why?
|
| Lipolysis | 1 | 2014 | 18 | 0.120 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2014 | 39 | 0.120 |
Why?
|
| Pyrazines | 1 | 2014 | 23 | 0.120 |
Why?
|
| Adipose Tissue | 2 | 2014 | 167 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2014 | 140 | 0.120 |
Why?
|
| Double-Blind Method | 6 | 2005 | 269 | 0.120 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 143 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2019 | 897 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2019 | 834 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2014 | 196 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2013 | 1349 | 0.110 |
Why?
|
| HIV Wasting Syndrome | 2 | 2004 | 7 | 0.110 |
Why?
|
| Imidazoles | 2 | 2009 | 124 | 0.100 |
Why?
|
| Pyridines | 2 | 2009 | 113 | 0.100 |
Why?
|
| Lipogenesis | 1 | 2011 | 18 | 0.100 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 31 | 0.100 |
Why?
|
| Mice, Obese | 3 | 2018 | 37 | 0.100 |
Why?
|
| Luteinizing Hormone | 5 | 2005 | 62 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 217 | 0.100 |
Why?
|
| Intracellular Space | 1 | 2010 | 35 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2014 | 775 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2006 | 984 | 0.090 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 129 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 396 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 126 | 0.090 |
Why?
|
| Female | 8 | 2014 | 19873 | 0.090 |
Why?
|
| Heart | 1 | 2011 | 178 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 1534 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2010 | 127 | 0.090 |
Why?
|
| Glucose | 1 | 2010 | 217 | 0.080 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2008 | 16 | 0.080 |
Why?
|
| Risk Factors | 2 | 2014 | 3414 | 0.080 |
Why?
|
| Caspase 9 | 1 | 2008 | 27 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2010 | 160 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 162 | 0.080 |
Why?
|
| Sex Hormone-Binding Globulin | 3 | 2005 | 18 | 0.080 |
Why?
|
| Spermatozoa | 1 | 2008 | 191 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2019 | 528 | 0.070 |
Why?
|
| Smoking | 1 | 2014 | 903 | 0.070 |
Why?
|
| Insulin Resistance | 2 | 2006 | 177 | 0.070 |
Why?
|
| Cell Death | 1 | 2007 | 260 | 0.070 |
Why?
|
| Rats | 2 | 2011 | 3261 | 0.070 |
Why?
|
| Body Fat Distribution | 1 | 2006 | 23 | 0.070 |
Why?
|
| Hormone Replacement Therapy | 1 | 2006 | 41 | 0.070 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2003 | 29 | 0.070 |
Why?
|
| Pregnancy | 1 | 2011 | 1503 | 0.070 |
Why?
|
| Biopsy | 1 | 2006 | 151 | 0.070 |
Why?
|
| Cell Division | 1 | 2006 | 296 | 0.070 |
Why?
|
| Postmenopause | 1 | 2005 | 125 | 0.070 |
Why?
|
| Leuprolide | 1 | 2004 | 8 | 0.070 |
Why?
|
| Androstenedione | 1 | 2004 | 16 | 0.070 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2004 | 34 | 0.060 |
Why?
|
| Sexual Behavior | 3 | 2005 | 587 | 0.060 |
Why?
|
| Hypogonadism | 1 | 2004 | 21 | 0.060 |
Why?
|
| Androgens | 1 | 2004 | 87 | 0.060 |
Why?
|
| Pluripotent Stem Cells | 1 | 2003 | 31 | 0.060 |
Why?
|
| Affect | 1 | 2005 | 147 | 0.060 |
Why?
|
| Biopsy, Needle | 2 | 2019 | 60 | 0.060 |
Why?
|
| Aged | 5 | 2006 | 6448 | 0.060 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2003 | 4 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1149 | 0.060 |
Why?
|
| Tissue Fixation | 1 | 2003 | 18 | 0.060 |
Why?
|
| Cell Size | 1 | 2003 | 42 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 605 | 0.060 |
Why?
|
| Dihydrotestosterone | 2 | 1999 | 26 | 0.060 |
Why?
|
| Reference Values | 2 | 2004 | 204 | 0.060 |
Why?
|
| Cytokines | 1 | 2006 | 569 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2004 | 490 | 0.050 |
Why?
|
| Cognition | 1 | 2005 | 373 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 2 | 1998 | 41 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2003 | 351 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 2128 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2003 | 555 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2004 | 1442 | 0.050 |
Why?
|
| Bed Rest | 1 | 1999 | 2 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1152 | 0.050 |
Why?
|
| Muscular Atrophy | 1 | 1999 | 12 | 0.050 |
Why?
|
| Triiodothyronine | 1 | 1999 | 30 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1998 | 4 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 139 | 0.040 |
Why?
|
| Dialysis | 1 | 1998 | 6 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 1999 | 1056 | 0.040 |
Why?
|
| Exercise | 2 | 2001 | 524 | 0.040 |
Why?
|
| Radioimmunoassay | 1 | 1998 | 66 | 0.040 |
Why?
|
| Energy Intake | 2 | 2011 | 160 | 0.040 |
Why?
|
| Adolescent | 6 | 2006 | 5035 | 0.040 |
Why?
|
| Administration, Topical | 2 | 2006 | 39 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 1998 | 901 | 0.030 |
Why?
|
| HIV-1 | 1 | 1998 | 678 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2012 | 26 | 0.030 |
Why?
|
| Animal Feed | 1 | 2012 | 42 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2011 | 21 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2012 | 101 | 0.030 |
Why?
|
| Adiposity | 1 | 2011 | 145 | 0.020 |
Why?
|
| Liver | 1 | 2012 | 447 | 0.020 |
Why?
|
| Administration, Cutaneous | 2 | 2000 | 38 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 11 | 0.020 |
Why?
|
| Fever | 1 | 2008 | 57 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 122 | 0.020 |
Why?
|
| Testis | 1 | 2008 | 185 | 0.020 |
Why?
|
| Placebo Effect | 1 | 2006 | 13 | 0.020 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2005 | 4 | 0.020 |
Why?
|
| Gels | 1 | 2005 | 41 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2005 | 91 | 0.020 |
Why?
|
| Thrombosis | 1 | 2006 | 61 | 0.020 |
Why?
|
| Menstruation | 1 | 2004 | 10 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2004 | 58 | 0.020 |
Why?
|
| California | 1 | 2006 | 436 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2004 | 63 | 0.020 |
Why?
|
| Exercise Test | 1 | 2004 | 68 | 0.020 |
Why?
|
| Insulin | 1 | 2006 | 224 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 608 | 0.020 |
Why?
|
| Comorbidity | 1 | 2006 | 606 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2003 | 48 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 317 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2004 | 202 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 123 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 650 | 0.010 |
Why?
|
| Stem Cells | 1 | 2003 | 132 | 0.010 |
Why?
|
| Apolipoproteins C | 1 | 2002 | 3 | 0.010 |
Why?
|
| Apolipoprotein C-III | 1 | 2002 | 6 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 2001 | 19 | 0.010 |
Why?
|
| Apolipoproteins B | 1 | 2002 | 18 | 0.010 |
Why?
|
| Body Water | 1 | 2001 | 26 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 485 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2001 | 35 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2002 | 87 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2004 | 562 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 1007 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2003 | 608 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2002 | 114 | 0.010 |
Why?
|
| Quality of Life | 1 | 2004 | 459 | 0.010 |
Why?
|
| Cholesterol | 1 | 2002 | 194 | 0.010 |
Why?
|
| Biological Availability | 1 | 2000 | 84 | 0.010 |
Why?
|
| Hormones | 1 | 2000 | 51 | 0.010 |
Why?
|
| Thigh | 1 | 2000 | 10 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 2000 | 20 | 0.010 |
Why?
|
| Head-Down Tilt | 1 | 1999 | 1 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 859 | 0.010 |
Why?
|
| Estradiol | 1 | 2002 | 244 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2002 | 333 | 0.010 |
Why?
|
| Thyroxine | 1 | 1999 | 17 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1999 | 15 | 0.010 |
Why?
|
| Weightlessness Simulation | 1 | 1999 | 15 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2003 | 1318 | 0.010 |
Why?
|
| CHO Cells | 1 | 1998 | 107 | 0.010 |
Why?
|
| Introns | 1 | 1998 | 67 | 0.010 |
Why?
|
| Exons | 1 | 1998 | 80 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 159 | 0.010 |
Why?
|
| Cricetinae | 1 | 1998 | 217 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 1998 | 73 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 310 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2000 | 212 | 0.010 |
Why?
|
| Cattle | 1 | 1998 | 472 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 455 | 0.010 |
Why?
|
| Base Sequence | 1 | 1998 | 932 | 0.010 |
Why?
|
| Emotions | 1 | 1998 | 204 | 0.010 |
Why?
|
| Child | 1 | 2003 | 2875 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 1490 | 0.010 |
Why?
|